This data sheet focuses on Clario’s centralized Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) services. DLCO is a critical pulmonary function test for assessing gas transfer in diseases such as asthma, COPD, IPF, and cystic fibrosis. The document highlights how lack of standardization can result in up to 50% variability across sites. Clario addresses this through centralized workflows, expert overread, real-time notifications, and integration of the ndd® EasyOne Pro device into the EXPERT® platform. Benefits include improved data quality, reduced site burden, enhanced oversight, and faster decision-making across global respiratory trials.

Join for free to read